Drug factory · FDA FEI 1000115423
Martin Ekwealor Pharmaceuticals, Inc.
Economy, Indiana, United States
Matched to FDA's records by company name, because this plant's registration on the label has expired.
No problems found at FDA's last inspection, Dec 13, 2017.
No Action Indicated: inspectors found no objectionable conditions.
3 drug inspections on record since 2010: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 13, 2017 | No problems found | Drug Quality Assurance | — |
| Jul 29, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 17, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | 1 |
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
Feb 17, 2010 inspection
- Written Procedures Not Followed 21 CFR 211.80(a)
Written procedures are not followed for the receipt and identification of components.